BIOMAT Database Logo BIOMAT Database Logo

Enhancement of HIV-1 infection by the capsular polysaccharide of Cryptococcus neoformans. 1992

M Pettoello-Mantovani, and A Casadevall, and T R Kollmann, and A Rubinstein, and H Goldstein
Department of Pediatrics, Albert Einstein College of Medicine, Bronx, New York 10461.

Patients with AIDS who become infected with Cryptococcus neoformans have a poor prognosis. We speculated that the presence of cryptococcal capsular polysaccharide may enhance HIV-1 infection. In an in-vitro study, the presence of cryptococcal polysaccharide significantly increased (p less than 0.05) production of p24 antigen after infection of H9 cells with HIV-1-infected H9 cells. We also found similar results when lymphocytes from an HIV-1-infected patient were co-cultured with mononuclear cells from an uninfected individual. Our findings suggest a new pathogenic role for the capsular polysaccharide--namely, the capacity to enhance HIV-1 infectivity.

UI MeSH Term Description Entries
D011134 Polysaccharides Long chain polymeric CARBOHYDRATES composed of MONOSACCHARIDES linked by glycosidic bonds. Glycan,Glycans,Polysaccharide
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003453 Cryptococcosis Fungal infection caused by genus CRYPTOCOCCUS. C gattii Infection,C neoformans Infection,C. gattii Infection,C. neoformans Infection,Cryptococcus Infection,Cryptococcus Infections,Cryptococcus gattii Infection,Torulosis,Cryptococcus neoformans Infection,C gattii Infections,C neoformans Infections,C. gattii Infections,C. neoformans Infections,Cryptococcoses,Cryptococcus gattii Infections,Cryptococcus neoformans Infections,Infection, C gattii,Infection, C neoformans,Infection, C. gattii,Infection, C. neoformans,Infection, Cryptococcus,Infection, Cryptococcus gattii,Infection, Cryptococcus neoformans,Infections, C gattii,Infections, C. neoformans,Toruloses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D012194 RNA-Directed DNA Polymerase An enzyme that synthesizes DNA on an RNA template. It is encoded by the pol gene of retroviruses and by certain retrovirus-like elements. EC 2.7.7.49. DNA Polymerase, RNA-Directed,RNA-Dependent DNA Polymerase,Reverse Transcriptase,RNA Transcriptase,Revertase,DNA Polymerase, RNA Directed,DNA Polymerase, RNA-Dependent,RNA Dependent DNA Polymerase,RNA Directed DNA Polymerase
D014775 Virus Activation The mechanism by which latent viruses, such as genetically transmitted tumor viruses (PROVIRUSES) or PROPHAGES of lysogenic bacteria, are induced to replicate and then released as infectious viruses. It may be effected by various endogenous and exogenous stimuli, including B-cell LIPOPOLYSACCHARIDES, glucocorticoid hormones, halogenated pyrimidines, IONIZING RADIATION, ultraviolet light, and superinfecting viruses. Prophage Excision,Prophage Induction,Virus Induction,Viral Activation,Activation, Viral,Activation, Virus,Activations, Viral,Activations, Virus,Excision, Prophage,Excisions, Prophage,Induction, Prophage,Induction, Virus,Inductions, Prophage,Inductions, Virus,Prophage Excisions,Prophage Inductions,Viral Activations,Virus Activations,Virus Inductions
D015496 CD4-Positive T-Lymphocytes A critical subpopulation of T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the T4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes. T4 Cells,T4 Lymphocytes,CD4-Positive Lymphocytes,CD4 Positive T Lymphocytes,CD4-Positive Lymphocyte,CD4-Positive T-Lymphocyte,Lymphocyte, CD4-Positive,Lymphocytes, CD4-Positive,T-Lymphocyte, CD4-Positive,T-Lymphocytes, CD4-Positive,T4 Cell,T4 Lymphocyte
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human

Related Publications

M Pettoello-Mantovani, and A Casadevall, and T R Kollmann, and A Rubinstein, and H Goldstein
IMMUNIZATION AGAINST CRYPTOCOCCUS NEOFORMANS BY CAPSULAR POLYSACCHARIDE.
August 1963, Nature,
M Pettoello-Mantovani, and A Casadevall, and T R Kollmann, and A Rubinstein, and H Goldstein
Detection of Cryptococcus neoformans capsular polysaccharide antigen in asymptomatic HIV-infected patients.
January 1995, Revista do Instituto de Medicina Tropical de Sao Paulo,
M Pettoello-Mantovani, and A Casadevall, and T R Kollmann, and A Rubinstein, and H Goldstein
[Monoclonal antibodies recognizing the capsular polysaccharide of Cryptococcus neoformans].
January 2005, Revista cubana de medicina tropical,
M Pettoello-Mantovani, and A Casadevall, and T R Kollmann, and A Rubinstein, and H Goldstein
Capsular localization of the Cryptococcus neoformans polysaccharide component galactoxylomannan.
January 2009, Eukaryotic cell,
M Pettoello-Mantovani, and A Casadevall, and T R Kollmann, and A Rubinstein, and H Goldstein
The major capsular polysaccharide of Cryptococcus neoformans serotype B.
September 1992, Carbohydrate research,
M Pettoello-Mantovani, and A Casadevall, and T R Kollmann, and A Rubinstein, and H Goldstein
Mechanism of action of antibody to capsular polysaccharide in Cryptococcus neoformans infection.
February 1998, Frontiers in bioscience : a journal and virtual library,
M Pettoello-Mantovani, and A Casadevall, and T R Kollmann, and A Rubinstein, and H Goldstein
Detection of circulating capsular polysaccharide antigen from Cryptococcus neoformans.
September 1992, Journal of clinical microbiology,
M Pettoello-Mantovani, and A Casadevall, and T R Kollmann, and A Rubinstein, and H Goldstein
A cryptococcal capsular polysaccharide mimotope prolongs the survival of mice with Cryptococcus neoformans infection.
January 2001, Journal of immunology (Baltimore, Md. : 1950),
M Pettoello-Mantovani, and A Casadevall, and T R Kollmann, and A Rubinstein, and H Goldstein
The structure of the capsular polysaccharide from Cryptococcus neoformans serotype D.
August 1979, Carbohydrate research,
M Pettoello-Mantovani, and A Casadevall, and T R Kollmann, and A Rubinstein, and H Goldstein
Capsular polysaccharide of Cryptococcus neoformans induces proinflammatory cytokine release by human neutrophils.
August 1996, Infection and immunity,
Copied contents to your clipboard!